CD8A and neoplasm: In addition, the depletion of CD8+ T cells dramatically compromised the anti‐tumor effect of PLGA‐POx‐Man nanovaccine, suggesting that CD8+ T cells are positively correlated with decreased tumor volume and the therapeutic benefit mediated by POx‐Man nanovaccine (Figure 2S,T and Figure S4B, Supporting Information).